Vimarsana
Biggest News Aggregation in the World

Page 20 - Eclipse Ventures News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Eclipse Ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Eclipse Ventures Today - Breaking & Trending Today

Skyryse Appoints Will Fulton as Vice President of Product and Marketing to Lead Commercialization of Its Flagship Product, FlightOS - Vimarsana News

Skyryse Appoints Will Fulton as Vice President of Product and Marketing to Lead Commercialization of Its Flagship Product, FlightOS

/PRNewswire/ -- Skyryse, a transportation company building the future of general aviation, has appointed Will Fulton as Vice President of Product and Marketing....

Quantifying Climate Impact Potential for Technologies Disrupting Physical Industries - Vimarsana News

Quantifying Climate Impact Potential for Technologies Disrupting Physical Industries

ECO helps investors identify the full promise and impact of technologies by quantifying sustainability and carbon reduction potential alongside economic ROI, what is said to be an industry first.

Eclipse Ventures Launches Framework to Quantify Climate Impact Potential for Technologies Disrupting Physical Industries - Vimarsana News

Eclipse Ventures Launches Framework to Quantify Climate Impact Potential for Technologies Disrupting Physical Industries

/PRNewswire/ -- Eclipse Ventures, a venture capital firm that helps founders build companies to make physical industries more efficient, resilient, and...

Global Roundup: Hansa, OSE Nab New Funding, F-Star Links with Takeda - Vimarsana News

Global Roundup: Hansa, OSE Nab New Funding, F-Star Links with Takeda

Hansa Biopharma secured $70 million in non-dilutive financing, OSE secured $300 million in funding while CN Bio opened a new contract research facility and more global biopharma news.

Global Roundup: Hansa, OSE Nab New Funding, F-Star Links with Takeda - Vimarsana News

Global Roundup: Hansa, OSE Nab New Funding, F-Star Links with Takeda

Hansa Biopharma secured $70 million in non-dilutive financing, OSE secured $300 million in funding while CN Bio opened a new contract research facility and more global biopharma news.